Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

General Employment Q3 Sales $38.10M Beat $34.31M Estimate

General Employment (AMEX:JOB) reported quarterly sales of $38.10 million which beat the analyst consensus estimate of $34.31 million by 11.05 percent. This is a 43.27 percent increase over sales of $26.59 million the
byBenzinga Newsdesk
August 16, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

General Employment (AMEX:JOB) reported quarterly sales of $38.10 million which beat the analyst consensus estimate of $34.31 million by 11.05 percent. This is a 43.27 percent increase over sales of $26.59 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Sermonix Pharmaceuticals Shares Additional Findings From Its Evaluation Of Lasofoxifene In ESR1 Mutations Phase 2 Study At The 4th Annual Congress Of The ISLB NOTE: Sermonix Licensed Lasofoxifene Globally From Ligand Pharmaceuticals

By Benzinga Newsdesk
Today, 2:47 AM
Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated metastatic breast and gynecological cancers, today shared additional

LGND